Contact
Please use this form to send email to PR contact of this press release:
Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021
TO:
Michael Kessler
Michael Kessler Media - EASL Media relations
+34 655 79 26 99